Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-05-09
2006-05-09
Wang, Shengjun (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S370000, C514S372000
Reexamination Certificate
active
07041694
ABSTRACT:
Selective inhibitors of cyclooxygenase-2 are used to treat liver disease and in combination with anti-viral drugs to treat virus-caused liver disorders. Selective inhibitors of cyclooxygenase-2 which also inhibit the synthesis of cyclooxygenase-2 improve over the efficacy of conventional selective inhibitors of cyclooxygenase-2 in the treatment of inflammatory conditions, Alzheimer's disease and cancer.
REFERENCES:
patent: 5436265 (1995-07-01), Black et al.
patent: 5466823 (1995-11-01), Talley et al.
patent: 5474995 (1995-12-01), Ducharme et al.
patent: 5510368 (1996-04-01), Lau et al.
patent: 5521213 (1996-05-01), Prasit et al.
patent: 5552422 (1996-09-01), Gauthier et al.
patent: 5593992 (1997-01-01), Adams et al.
patent: 5593994 (1997-01-01), Batt et al.
patent: 5596008 (1997-01-01), Lee
patent: 5604253 (1997-02-01), Lau et al.
patent: 5604260 (1997-02-01), Guay et al.
patent: 5616458 (1997-04-01), Lipsky et al.
patent: 5616601 (1997-04-01), Khanna et al.
patent: 5633272 (1997-05-01), Talley et al.
patent: 5639780 (1997-06-01), Lau et al.
patent: 5643933 (1997-07-01), Talley et al.
patent: 6048850 (2000-04-01), Young et al.
patent: 6172096 (2001-01-01), Gregory
patent: WO 97/29776 (1997-08-01), None
Seibert et al. CAPLUS Abstract, AN 1998:369098, 1997.
Jeng et al. “Secondary Biliary Cirrhosis A Limiting Factor in the Treatment of Hepatolithiasis”Arch Surgvol. 124 pp. 1301-1305, 1989.
Hurizinga et al. “Chronic Pancreatitis with Biliary Obstruction”Annals of the Royal College of Surgeons of Englandvol. 74 pp 119-125, 1992.
Haslam, E., “Protection of Phenols and Catechols” in Protective Groups in Organic Chemistry, McOmie, J. F. W., editor, Plenum Press, New York (1973).
Dinchuk, J. E., Nature 378, 406-409 (1995).
Nanji, A. A., et al., Gastroenterology 112, 943-951 (1997).
Branca, A., et al., Derwent Abstract of WO 9639144 A1, AN 97-042830.
Penning, T. D., et al., HCAPLUS Abstract AN 1997:231026 of J. Med. Chem. 1997, 40(9), 1347-1365.
Nanji A. A., et al., Hepatology 26(6), 1538-1543 (1997).
Denda, A., et al., Carcinogenesis 18, 1921-1930 (1997).
Albrecht, C., et al., Hepatology 26, No. 4, Part 2, 333A (Abstract 818) (1997).
Bacon & Thomas PLLC
Cornell Research Foundation Inc.
Wang Shengjun
LandOfFree
Cyclooxygenase-2 inhibition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclooxygenase-2 inhibition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclooxygenase-2 inhibition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3545650